| SICS’s mission: The Singapore Institute for Clinical Sciences (SICS) will accelerate the translation of basic discoveries into new diagnostics and therapeutics. This institute will be distinguished by its focus on clinical science and the use of innovative approaches and technologies that enable the efficient and effective study of human health and disease. In so doing, the institute will attract, train and nurture a new type of clinician scientist. The institute will collaborate with universities, research institutes and clinical programs to achieve the ultimate goal of improving human health as well as Singapore’s economic well-being. The research focus of SICS will be centered on the human as the model system, and will complement other A*STAR Research Institutes (RIs) by focusing on the clinical and translational research portion of the spectrum of biomedical research. SICS will have both intramural research programs and extramural outreach initiatives. Intramural Programs are focused on specific disease areas. The initial programs at SICS are as follows: o Growth, Development and Metabolism o Infection and Immunity o Cancer SICS participates in, or provides oversight to programs external to our institute through our Extramural Programs: o Lilly-NUS/SICS Joint Fellowship o Metabolic Interest Group
| | | |
|